MET and prostate carcinoma: PIM1, in turn, was shown to enhance the growth of lung adenocarcinoma by potentiating the c-MET signaling pathway [41] and the growth of prostate carcinoma [48] and triple-negative breast cancer [49] in cooperation with MYC.